# Xenon Pharmaceuticals Inc. (XENE): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/xene for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company operates primarily from its headquarters in Burnaby, Canada. Its robust clinical pipeline showcases several promising candidates: XEN496, an activator of Kv7 potassium channels, is currently in Phase III clinical trials for KCNQ2 developmental and epileptic encephalopathy. Another Kv7 potassium channel activator, XEN1101, is progressing through Phase II trials, targeting epilepsy and a range of o...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $35.34 USD |
| Market Cap | $3.42B |
| P/E (TTM) | — |
| EPS (TTM) | −$4.74 |
| 52-Week Range | $33.38 – $72.66 |
| Dividend Yield (TTM) | — |

## Dividend

XENE has no dividend payment history in our records.

## Frequently Asked Questions

### What does Xenon Pharmaceuticals Inc. do?

Xenon Pharmaceuticals Inc. (XENE) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is XENE's market cap?

Xenon Pharmaceuticals Inc. (XENE) has a market capitalization of approximately $3.42 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does XENE pay a dividend?

No, Xenon Pharmaceuticals Inc. (XENE) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is XENE profitable?

Xenon Pharmaceuticals Inc. (XENE) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has XENE ever paid a dividend?

No. Dividend Data's records show no dividend payments from Xenon Pharmaceuticals Inc. (XENE). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/xene
- Dividend history & safety: https://www.dividenddata.com/stocks/xene/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/xene/earnings
- Financial statements: https://www.dividenddata.com/stocks/xene/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/xene/valuation
- Peer comparison: https://www.dividenddata.com/stocks/xene/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.